From Hype To Reality, AI Reshapes Pharmaceutical Industry Across Drug Discovery To Marketing - Stocks To Watch

Pharmaceutical companies have been at the forefront of artificial intelligence for quite some time. Researchers have been using advanced AI models to understand disease mechanisms even before the recent surge in interest. Wednesday, researchers at Alphabet Inc’s (NASDAQ:GOOG) (NASDAQ:GOOGL) Google DeepMind developed AlphaFold 3, a new artificial intelligence (AI) model. AlphaFold 3 can predict the structure and interactions of biological molecules. This includes proteins, DNA, RNA, and sma